Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study.
Because both ovarian and breast cancer are hormone-related and are known to have some predisposition genes in common, we evaluated 11 of the most significant hits (six with confirmed associations with breast cancer) from the breast cancer genome-wide association study for association with invasive ovarian cancer. Eleven SNPs were initially genotyped in 2927 invasive ovarian cancer cases and 4143 controls from six ovarian cancer case-control studies. Genotype frequencies in cases and controls were compared using a likelihood ratio test in a logistic regression model stratified by study. Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNRC9) were weakly associated with ovarian cancer risk and one SNP (rs4954956 in NXPH2) was associated with serous ovarian cancer in non-Hispanic white subjects (P-trend < 0.1). These four SNPs were then genotyped in an additional 4060 cases and 6308 controls from eight independent studies. Only rs4954956 was significantly associated with ovarian cancer risk both in the replication study and in combined analyses. This association was stronger for the serous histological subtype [per minor allele odds ratio (OR) 1.07 95% CI 1.01-1.13, P-trend = 0.02 for all types of ovarian cancer and OR 1.14 95% CI 1.07-1.22, P-trend = 0.00017 for serous ovarian cancer]. In conclusion, we found that rs4954956 was associated with increased ovarian cancer risk, particularly for serous ovarian cancer. However, none of the six confirmed breast cancer susceptibility variants we tested was associated with ovarian cancer risk. Further work will be needed to identify the causal variant associated with rs4954956 or elucidate its function.
Song
Honglin
H
CR-UK Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Cambridge, UK. honglin@srl.cam.ac.uk
Ramus
Susan J
SJ
Kjaer
Susanne Krüger
SK
DiCioccio
Richard A
RA
Chenevix-Trench
Georgia
G
Pearce
Celeste Leigh
CL
Hogdall
Estrid
E
Whittemore
Alice S
AS
McGuire
Valerie
V
Hogdall
Claus
C
Blaakaer
Jan
J
Wu
Anna H
AH
Van Den Berg
David J
DJ
Stram
Daniel O
DO
Menon
Usha
U
Gentry-Maharaj
Aleksandra
A
Jacobs
Ian J
IJ
Webb
Penny M
PM
Beesley
Jonathan
J
Chen
Xiaoqing
X
Rossing
Mary Anne
MA
Doherty
Jennifer A
JA
Chang-Claude
Jenny
J
Wang-Gohrke
Shan
S
Goodman
Marc T
MT
Lurie
Galina
G
Thompson
Pamela J
PJ
Carney
Michael E
ME
Ness
Roberta B
RB
Moysich
Kirsten
K
Goode
Ellen L
EL
Vierkant
Robert A
RA
Cunningham
Julie M
JM
Anderson
Stephanie
S
Schildkraut
Joellen M
JM
Berchuck
Andrew
A
Iversen
Edwin S
ES
Moorman
Patricia G
PG
Garcia-Closas
Montserrat
M
Chanock
Stephen
S
Lissowska
Jolanta
J
Brinton
Louise
L
Anton-Culver
Hoda
H
Ziogas
Argyrios
A
Brewster
Wendy R
WR
Ponder
Bruce A J
BA
Easton
Douglas F
DF
Gayther
Simon A
SA
Pharoah
Paul D P
PD
D001943:Breast Neoplasms / Q000235:genetics*; D016022:Case-Control Studies; D005260:Female; D020022:Genetic Predisposition to Disease; D055106:Genome-Wide Association Study; D006023:Glycoproteins / Q000235:genetics; D006801:Humans; D009479:Neuropeptides / Q000235:genetics; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000473:pathology; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors; D044465:White People / Q000235:genetics
D006023:Glycoproteins; D009479:Neuropeptides; C112162:neurexophilin